谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Preliminary Efficacy and Safety Results from RC48-C017: A Phase II Study of Neoadjuvant Treatment with Disitamab Vedotin Plus Toripalimab in Patients with Muscle Invasive Bladder Cancer (MIBC) with HER2 Expression.

Xinan Sheng,Kaiwei Yang,Yongpeng Ji,Li Zhou,Benkui Zou, Hang Huang,Yonghua Wang,Xue Bai, Dan Feng,Yong Yang,Jiasheng Bian, Zhixian Yu, Haitao Niu,Peng Du, Jianmin Fang,Zhisong He,Jun Guo

Journal of Clinical Oncology（2024）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要